The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

NCT03604406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Herpes Zoster
Inflammatory Disease
Rheumatoid Arthritis

Interventions

BIOLOGICAL: Varicella Zoster Vaccine
OTHER: Placebo Injection
BIOLOGICAL: Varicella Zoster Vaccine

Sponsor

Kevin Winthrop

Collaborators

[object Object]
[object Object]